GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Silver Spike Investment Corp (NAS:SSIC) » Definitions » Peter Lynch Fair Value

Silver Spike Investment (Silver Spike Investment) Peter Lynch Fair Value : N/A (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Silver Spike Investment Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Silver Spike Investment's Peter Lynch Fair Value or its related term are showing as below:



SSIC's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.41
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Silver Spike Investment Peter Lynch Fair Value Historical Data

The historical data trend for Silver Spike Investment's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Silver Spike Investment Peter Lynch Fair Value Chart

Silver Spike Investment Annual Data
Trend Mar21 Mar22 Dec23
Peter Lynch Fair Value
- - -

Silver Spike Investment Quarterly Data
Jun21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Silver Spike Investment's Peter Lynch Fair Value

For the Drug Manufacturers - Specialty & Generic subindustry, Silver Spike Investment's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Silver Spike Investment's Price-to-Peter-Lynch-Fair-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Silver Spike Investment's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Silver Spike Investment's Price-to-Peter-Lynch-Fair-Value falls into.



Silver Spike Investment Peter Lynch Fair Value Calculation

Silver Spike Investment's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM Book Value Growth Rate***EPS without NRI (TTM)
=1* N/A *2.25
=N/A

Silver Spike Investment's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $2.25.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM Book Value Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data is the latest quarter data. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Silver Spike Investment  (NAS:SSIC) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of Book Value per share over the past 5 years, which is 0 instead of 15 in this case.

Silver Spike Investment's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=11.44/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Silver Spike Investment Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Silver Spike Investment's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Silver Spike Investment (Silver Spike Investment) Business Description

Traded in Other Exchanges
N/A
Address
600 Madison Avenue, Suite 1800, New York, NY, USA, 10022
Silver Spike Investment Corp is a closed-end management investment company formed to invest in companies across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately-held cannabis businesses.
Executives
Umesh Mahajan officer: Chief Financial Officer 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Scott Gordon director, 10 percent owner, officer: Chief Executive Officer 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Gregory M. Gentile 10 percent owner, officer: CFO, CCO & Sec. 1114 6TH AVE, 41ST FLOOR, NEW YORK NY 10036
Silver Spike Capital, Llc 10 percent owner 600 MADISON AVE, SUITE 1800, NEW YORK NY 10022
Warson Tracey Brophy director 1350 AVENUE OF THE AMERICAS, NEW YORK NY 10019
Silver Spike Holdings, Lp 10 percent owner 600 MADISON AVENUE, SUITE 1800, NEW YORK NY 10022
Michael William Chorske director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Vivek Bunty Bohra director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Silver Spike Holdings Gp, Llc 10 percent owner 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065
Da Corte Americo director 660 MADISON AVENUE, SUITE 1600, NEW YORK NY 10065